Five-year results of brentuximab vedotin in patients with relapsed or refractory systemic anaplastic large cell lymphoma

Barbara Pro, Ranjana Advani, Pauline Brice, Nancy L. Bartlett, Joseph D. Rosenblatt, Tim Illidge, Jeffrey Matous, Radhakrishnan Ramchandren, Michelle Fanale, Joseph M. Connors, Keenan Fenton, Dirk Huebner, Juan M. Pinelli, Dana A. Kennedy, Andrei Shustov

Research output: Contribution to journalArticlepeer-review

123 Scopus citations

Fingerprint

Dive into the research topics of 'Five-year results of brentuximab vedotin in patients with relapsed or refractory systemic anaplastic large cell lymphoma'. Together they form a unique fingerprint.

Medicine & Life Sciences

Chemical Compounds